UNSPSC 85814510: Introduction of anti-inflammatory into female reproductive, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into female reproductive, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0P83Z

UNSPSC 85814510 (Introduction of anti-inflammatory into female reproductive, via natural or artificial opening endoscopic), a Commodity code, shows no recent state and local procurement activity aligned with its clinical scope; the opportunities tagged under this code describe virtual urgent care, medical services, occupational health, cancer screening, orthotic services, EMS staffing, and behavioral health programs entirely unrelated to gynecological anti-inflammatory treatment.

The mismatch between code and recent solicitations indicates either persistent classification errors in state and local procurement systems or a code with minimal current activity in the public contracting space. State and local governments do procure clinical and diagnostic services extensively—as evidenced by opportunities from California Health Authority virtual care (RFI, October 31, 2026 response date), DeKalb County medical services (RFP, November 12, 2026), San Mateo County cancer registry (RFP, November 6, 2026), and Nevada Health Authority PACE operations (RFP, December 10, 2026)—but none of these represent gynecological procedures or anti-inflammatory administration. The code should be deprioritized unless your firm has direct relationships with state or local health systems purchasing endoscopic gynecological treatments or unless reclassification signals emerge in future solicitations.